02 May 2003 : Original article
Functional study of poly(ADP-ribose) glycohydrolase (PARG)
U. Cortes, W. Tong, Z. Herceg, V. Petrilli, E. Jacobson, M. Jacobson, Z. WangMed Sci Monit 2003; 9(1): 14- :: ID: 15061
Abstract
Poly(ADP-ribosyl)ation of proteins is one of the earliest responses to DNA damage in most eukaryotic cells. This posttranslational modification of nuclear proteins is achieved by the enzyme poly(ADP-ribose) polymerase (PARP-1), which synthesizes branched polymers of ADP-ribose (pADPr). Poly(ADP-ribose) polymers are then rapidly catabolized by the degrading enzyme poly(ADP-ribose) glycohydrolase (PARG). Although inhibition or depletion of PARP-1 demonstrates that PARP-1 and poly(ADP-ribosyl)ation play a role in cell proliferation and death, stress response, cell toxicity, DNA repair, recombination, and chromosomal stability, the exact functions of poly(ADP-ribosyl)ation and PARP-1 are largely unknown. This may be due to insufficient knowledge about PARG function, since only a few studies regarding pADPr catabolism have been performed. To better define the functions of PARG and poly(ADP-ribosyl)ation in vivo, we disrupted the PARG gene in ES cells by homologous recombination. Intercrossing of PARG heterozygous (PARG+/D) mice produced a normal mendelian ratio of PARG+/+, PARG+/D and PARGD/D offspring. Interestingly, homozygous PARG knockout mice developed normally, and were healthy and fertile. Expression analysis demonstrated the absence of PARG mRNA in PARGD/D cells and mice, and in the PARG+/D cells, PARG expression was at half of that of wild-type counterparts. These data indicate that PARG is not essential for normal development. Detailed analysis of pADPr metabolism in PARGD/D cells and inflammation response of PARGD/D mice indicate that PARG activity is important for controlling PARP-1 activity in vivo, possibly by regulating its auto-modifications.
Keywords: PARG, Poly(ADP-ribosyl)ation, Gene Targeting
246 0
Editorial
01 May 2023 : Editorial
Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor TherapyDOI: 10.12659/MSM.940911
Med Sci Monit 2023; 29:e940911
In Press
28 May 2023 : Database Analysis
Scientometric and Visualized Analysis of Intravoxel Incoherent Motion Magnetic Resonance Imaging: 1988-2021Med Sci Monit In Press; DOI: 10.12659/MSM.938715
25 May 2023 : Database Analysis
The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940904
25 May 2023 : Review article
A Review of Preclinical and Clinical Studies in Support of the Role of Non-Steroidal Anti-Inflammatory Drug...Med Sci Monit In Press; DOI: 10.12659/MSM.940635
25 May 2023 : Clinical Research
Periapical Lesions and Missed Canals in Endodontically Treated Teeth: A Cone-Beam Computed Tomographic Stud...Med Sci Monit In Press; DOI: 10.12659/MSM.940533
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952